Efficacy and Safety Study of Fosaprepitant (MK-0517) Plus Ondansetron Versus Ondansetron Alone for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Pediatric Participants (MK-0517-044)
Clinical trial NCT02519842 · TERMINATED
Trial details
- NCT number
- NCT02519842
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-14
- Primary completion
- 2017-02-24
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.